Nina Zimmermann
Overview
Explore the profile of Nina Zimmermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vogler S, Zimmermann N, Knoll V, Salcher-Konrad M, Windisch F, Espin J, et al.
J Pharm Policy Pract
. 2025 Jan;
17(Suppl 1):2442002.
PMID: 39763616
On 25-26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented...
2.
Vogler S, Zimmermann N, Haasis M, Knoll V, Espin J, Mantel-Teeuwisse A, et al.
J Pharm Policy Pract
. 2024 May;
17(Suppl 1):2335492.
PMID: 38757122
Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in...
3.
Lang S, Zimmermann N, Bernhardt T, Barnett R, Yoon B, Landman U
J Phys Chem Lett
. 2021 May;
12(22):5248-5255.
PMID: 34048261
Gas-phase ion-trap reactivity experiments and density functional simulations reveal that water oxidation to HO mediated by (calcium) manganese oxide clusters proceeds via formation of a terminal oxyl radical followed by...
4.
Vogler S, Zimmermann N, Babar Z, Busse R, Espin J, Mantel-Teeuwisse A, et al.
J Pharm Policy Pract
. 2021 Jan;
14(1):18.
PMID: 33494798
The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and...
5.
Zimmermann N, Bernhardt T, Bakker J, Barnett R, Landman U, Lang S
J Phys Chem A
. 2020 Jan;
124(8):1561-1566.
PMID: 31994885
The interaction of manganese oxide clusters MnO ( = 2-5, ≥ ) with CO is studied via infrared multiple-photon dissociation spectroscopy (IR-MPD) in the spectral region of 630-1860 cm. Along...
6.
Zimmermann N, Bernhardt T, Bakker J, Landman U, Lang S
Phys Chem Chem Phys
. 2019 Oct;
21(43):23922-23930.
PMID: 31661104
Infrared multiple-photon dissociation (IR-MPD) spectroscopy and density functional theory (DFT) calculations have been employed to elucidate the geometric structure of a series of di-manganese oxide clusters MnO (x = 4-7)....
7.
Vogler S, Schneider P, Zimmermann N
Pharmacoecon Open
. 2019 Feb;
3(3):303-309.
PMID: 30721410
Background: There are indications of staggered market entry of medicines in the national markets, with medicines being marketed first in countries with high prices. This study aimed to analyse the...
8.
Vogler S, Zimmermann N, de Joncheere K
Health Policy
. 2016 Oct;
120(12):1363-1377.
PMID: 27720165
Background: Policy-makers can use a menu of pharmaceutical policy options. This study aimed to survey these measures that were implemented in European countries between 2010 and 2015. Methods: We did...
9.
Vogler S, Zimmermann N, Babar Z
Expert Rev Pharmacoecon Outcomes Res
. 2016 Sep;
17(2):221-230.
PMID: 27658050
Background: In recent years, high-cost medicines have increasingly been challenging the public health budget in all countries including high-income economies. In this context, this study aims to survey, analyze and...
10.
Vogler S, Zimmermann N, Ferrario A, Wirtz V, de Joncheere K, Bak Pedersen H, et al.
J Pharm Policy Pract
. 2016 Mar;
9:9.
PMID: 26981252
In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The...